Anthropic Debuts Claude Fable 5 for Life Sciences

Anthropic has released its most powerful "Mythos-class" AI models, Claude Fable 5 and Mythos 5 ^[1][2][3]. These systems are specifically designed to support life sciences research by accelerating drug design processes tenfold ^[1]. The technology represents a new tier of underlying model capability featuring advanced safeguard layers tailored for sensitive research environments ^[2][3].

During development, the models autonomously identified protein binding sites and proposed a new antimicrobial target in E. coli ^[1][3]. Laboratory testing subsequently validated these findings, demonstrating the potential for AI to drive tangible breakthroughs in clinical science ^[1]. These models use the same core architecture but utilize different safety protocols to balance utility and risk in scientific discovery ^[2].